This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

XL475

Bristol-Myers Squibb Company

Drug Names(s): TGR5 agonist

Description: XL475 is a TGR5 agonist.

Deal Structure: The program was outlicensed to Bristol Myers Squibb in October 2010.

Partners: Exelixis, Inc.


XL475 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug